IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo E. Pérgola, Dominic S. Raj, Peter Libby, Michael Davidson
Topics & Concepts
MedicinePlaceboInternal medicinePopulationClinical trialKidney diseaseBiomarkerRandomized controlled trialPathologyChemistryBiochemistryAlternative medicineEnvironmental healthAdipokines, Inflammation, and Metabolic DiseasesInflammasome and immune disordersLipoproteins and Cardiovascular Health